|
FAM91A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.958600E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.446000E-01 |
| Normal-vs-Stage2 |
2.588200E-02 |
| Normal-vs-Stage3 |
1.525790E-02 |
| Normal-vs-Stage4 |
1.734830E-01 |
| Stage1-vs-Stage2 |
1.131610E-01 |
| Stage1-vs-Stage3 |
4.510200E-02 |
| Stage1-vs-Stage4 |
2.236800E-01 |
| Stage2-vs-Stage3 |
8.614800E-01 |
| Stage2-vs-Stage4 |
6.024400E-01 |
| Stage3-vs-Stage4 |
6.644400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.037900E-02 |
| Normal-vs-AfricanAmerican |
9.787600E-02 |
| Normal-vs-Asian |
4.002000E-01 |
| Caucasian-vs-AfricanAmerican |
6.303200E-01 |
| Caucasian-vs-Asian |
5.657000E-01 |
| AfricanAmerican-vs-Asian |
7.156000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.200790E-01 |
| Normal-vs-Female |
9.168100E-04 |
| Male-vs-Female |
2.668300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.739600E-01 |
| Normal-vs-Extreme_Weight |
7.472600E-01 |
| Normal-vs-Obese |
1.608340E-02 |
| Normal-vs-Extreme_Obese |
6.181600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.361200E-01 |
| Normal_Weight-vs-Obese |
1.852370E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.352200E-01 |
| Extreme_Weight-vs-Obese |
4.033800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.065400E-01 |
| Obese-vs-Extreme_Obese |
4.742000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.139700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.417720E-03 |
| Normal-vs-Age(61-80Yrs) |
4.645000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.850800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.416400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.277900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.640100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.690300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.271240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.866400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.087600E-02 |
| Normal-VS-Type2 PRCC |
1.746410E-01 |
| Normal-VS-KIRP CIMP |
4.153900E-02 |
| Normal-VS-Unclassified PRCC |
1.190000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.775800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.281800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.358800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.317990E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.247200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.472600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.410400E-01 |
| Normal-vs-N1 |
1.145840E-02 |
| Normal-vs-N2 |
6.127400E-01 |
| N0-vs-N1 |
3.470100E-02 |
| N0-vs-N2 |
6.817600E-01 |
| N1-vs-N2 |
5.078400E-01 |
|
|
